Skip to main content
logo
Anatara Lifesciences Ltd (ASX:ANR)
Australia flag Australia · Delayed Price · Currency is AUD
0.0090
0.00 (0.00%)
Aug 11, 2026, 3:47 PM AEST

Anatara Lifesciences Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
0.620.970.64---
Revenue Growth
-35.66%50.53%----
Gross Profit
-0.23-0.63-0.1-1.6-0.75-0.84
Operating Income
-1.3-1.96-1.46-2.05-2.53-2.04
Net Income
-1.31-1.95-1.45-2.02-2.53-2
Earnings Per Share
-0.01-0.01-0.01-0.02-0.04-0.03
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
1.090.10.980.41.173.43
Total Debt
-0.41--0.070.08
Net Cash (Debt)
1.09-0.310.980.41.13.35
Net Cash Growth
--144.80%-63.67%-67.05%24.97%
Net Cash Per Share
0.00-0.000.010.000.020.05

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-1.09-2.27-1.25-2.26-2.23-2.1
Capital Expenditures
----0-0.01-0
Free Cash Flow
-1.09-2.27-1.25-2.26-2.24-2.1
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
-37.01%-65.39%-16.29%---
Operating Margin
-209.05%-201.83%-226.56%---
Pretax Margin
-209.79%-201.63%-225.34%---
Profit Margin
-209.79%-201.63%-225.34%---
FCF Margin
-174.82%-234.36%-193.69%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-75.0075.0075.0075.0075.00
PS Ratio
4.561.1012.47---